Eisner Mark's Form 4 filing
Vir Biotechnology, Inc. (VIR) · filed Feb 26, 2026
- Accession no.
- 0001628280-26-012394
- Filed
- Feb 26, 2026
- Trade date
- Feb 24-25, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $34.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Eisner MarkCIK 0001834161 | Officer (EVP and Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 24, 2026 | Common Stock | SSaleDisposed | −1,616 | $9.53 | −$15,400.48 | 155,913 | Direct | |
| Feb 25, 2026 | Common Stock | SSaleDisposed | −1,889 | $9.82 | −$18,549.98 | 154,024 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.